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FluorescenceAbstract The quinoline hydrazone ligands were synthesized through multi-step reactions.
The 2-hydroxy-3-formylquinoline derivatives (1a–1c) were prepared from acetanilide derivatives
as starting materials using Vilsmeier–Haack reaction. Then the condensation of 2-hydroxy-3-
formylquinoline derivatives with hydrazide derivatives (2a–2c) yielded quinoline hydrazone ligands
(3a–3i). The synthesis of a new series of Zn(II) complexes carried out by reﬂuxing with these quino-
line hydrazone ligands (3a–3i) is reported. The molecular structures of the ligands (3a–3i) and the
Zn complexes were characterized by elemental analysis and spectral studies like FT-IR, 1H and 13C
NMR, MS, UV–Visible and ﬂuorescence. The preliminary results of antituberculosis study showed
that most of the Zn(II) complexes 4a–4i demonstrated very good antituberculosis activity while the
ligands 3a–3i showed moderate activity. Among the tested compounds 4e and 4g were found to be
most active with minimum inhibitory concentration (MIC) of 8.00lM and 7.42 lM respectively
againstMycobacterium tuberculosis (H37 RV strain) ATCC No-27294 which is comparable to ‘‘ﬁrst
and second line” drugs used to treat tuberculosis.
 2016 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The extremely drug resistant tuberculosis is a worldwide public
health problem in recent years. The wide spread of this disease
is primarily due to the development of resistance to the existing
drugs that has concerned researchers throughout the world.
There is an urgent requirement of improvement in new drugline and
2 M.C. Mandewale et al.molecules with newer targets and with an alternative mecha-
nism of action [1,2]. It is evident from the literature that
quinoline-based hydrazone scaffolds are known to exhibit
excellent anti-TB properties [3–8]. This broad spectrum of bio-
logical and biochemical activities has been further aided by the
synthetic ﬂexibility of quinoline hydrazones, which allows the
generation of a large number of structurally diverse derivatives
and their metal complexes [9,10]. Further, various types of
hydrazones have attracted continued interest in the medicinal
ﬁeld due to their broad-spectrum biological activities [11].
Among the ligand systems, quinoline hydrazone derivatives
are highly important because, these ligands developed due to
their diverse chelating ability, structural ﬂexibility and phar-
macological activities like antitumoural, antifungal, antibacte-
rial, antituberculosis, antimalarial, and antiviral [12,13].
Zinc is an important trace element in human beings, and is
participating in several biological processes in the form of
complexes with proteins and nucleic acids. Moreover, Zn(II)
ions are important for the expression of genetic information
and structural maintenance of chromatin [14–17]. Numerous
examples of Zn(II) complexes have been investigated for their
signiﬁcant antibacterial activity [18].
Recently it is reported that quinoline hydrazones and their
Zn(II) complexes showed signiﬁcant activity against the
Mycobacterium tuberculosis strain, at low micromolar levels
[19,20,10]. Based on these facts, supported by literature and
in continuation of our research for new antituberculosis agents
[21,22], we have undertaken research studies on synthesis and
biological screening of some new quinoline hydrazone deriva-
tives and their Zn(II) complexes shown in Fig. 1.
2. Experimental
The melting points of synthesized compounds were determined
in open capillary tubes and are uncorrected. UV–Visible spec-
tra were obtained on Shimadzu UV-1800 spectrophotometer.
The ﬂuorescence spectra were recorded on a spectroﬂuoropho-N
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Figure 1 Previously reported quinoline hydrazones as
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ette of 1 cm path length. Infrared spectra were measured
with KBr disc on a FTIR-7600 Lambda Scientiﬁc Pty. Ltd.
in the range 4000–400 cm1. Mass spectra were performed
on BRUKER ESQUIRE HCT spectrometer. 1H NMR and
13C NMR spectra were recorded on Varian-NMR-Mercury
300 MHz instruments in DMSO-d6 using tetramethylsilane
(TMS) as an internal standard; chemical shifts are reported
as d ppm units. The elemental analyses were done at the
SAIF, IIT Mumbai, India. The DSC–TGA analysis was
carried out on Universal V4.5A TA instrument. Thin-layer
chromatography (TLC) was performed on pre-coated TLC
sheets of silica gel 60 F254 (Merck, Darmstadt, Germany),
visualized by long- and short-wavelength UV lamps. Chro-
matographic puriﬁcations were performed on Merck silica
gel (60120 mesh).
2.1. General procedure for preparation of hydrazones 3a–3i and
Zn(II) complexes 4a–4i
A mixture of compound 1a–1c (0.01 mol) and appropriate
hydrazide derivatives 2a–2c (0.01 mol) in 10 mL of ethanol
was stirred for 30 min at 60 C. Completion of reaction is
checked with TLC. The reaction mixture was allowed
to cool down to room temperature and the solid formed was
ﬁltered, dried and recrystallized from ethanol to afford hydra-
zones 3a–3i. Their structures are represented in Table 1 and
Fig. 2.
A solution of Zinc chloride dissolved in ethanol was added
gradually to a stirred ethanolic solution of the hydrazone
ligand 3a–3i in the molar ratio 1:2. The reaction mixture was
further stirred for 2–4 h at 60 C. The reaction mixture was
allowed to cool down to room temperature and the solid
formed was ﬁltered, and washed several times with water.
Finally, the complexes 4a–4i were washed with diethyl ether
and dried in vacuum desiccators over anhydrous CaCl2. Prob-
able structures are presented in Table 2 and Fig. 2.N
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Table 1 Structures of hydrazones 3a–3i.
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Figure 2 Preparation of hydrazones 3a–3i and Zn(II) complexes 4a–4i.
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Table 2 Preparation of Zn(II) complexes 4a–4i.
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4 M.C. Mandewale et al.2.1.1. N0-[(E)-(2-hydroxyquinolin-3-yl)methylidene]pyridine-
3-carbo hydrazide [3a]
M.P.: 296 C; colour: pale yellow; MS [M+2]: 294.80; FTIR
(KBr cm1): 3237 (phenolicAOH), 3093 (NAH amide), 1662
(C‚O amide), 1596 (imine ACH‚NA), 1486 (phenolic
CAO); 1H NMR (DMSO-d6) d: 7.19–7.24 (m, 1H), 7.33–7.36
(m, 1H), 7.52–7.58 (m, 2H), 7.85–7.88 (d, 1H), 8.27–8.29 (d,
1H), 8.49 (s, 1H), 8.72–8.76 (m, 2H), 9.09 (s, 1H), 12.02 (s,
1H), 12.13 (s, 1H); 13C NMR (DMSO-d6) d: 124.5, 125.9,
127.1, 128.0, 128.7, 128.8, 129.0, 130.5, 130.2, 134.5, 147.2,
147.1, 147.9, 149.8 (C‚N), 160.8 (CAOH), 163.1 (AC‚O);Please cite this article in press as: M.C. Mandewale et al., Synthesis, structural studie
their Zn(II) complexes, Journal of Saudi Chemical Society (2016), http://dx.doi.orgelemental analysis [C16H12N4O2] observed (calculated): C
65.79% (65.75%), H 4.11% (4.14%), N 19.22% (19.17%).
2.1.2. N0-[(E)-(2-hydroxyquinolin-3-yl)methylidene]-6-
methylpyridine-3-carbohydrazide [3b]
M.P.: 286 C; colour: faint yellow; MS [M+H]: 307.02; FTIR
(KBr cm1): 3453 (phenolicAOH), 3237 (NAH amide), 3048
(aromatic CAH), 1660 (C‚O amide), 1600 (imine
ACH‚NA), 1432 (phenolic CAO); 1H NMR (DMSO-d6) d:
2.55 (s, 1H), 7.19–7.24 (m, 1H), 7.33–7.43 (m, 2H), 7.52–7.56
(m, 1H), 7.85–7.88 (m, 1H), 8.17–8.19 (m, 1H), 8.48 (s, 1H),s and antituberculosis evaluation of new hydrazone derivatives of quinoline and
/10.1016/j.jscs.2016.04.003
Hydrazone derivatives of quinoline and their Zn(II) complexes 58.71 (s, 1H), 8.97 (s, 1H), 12.04 (s, 1H), 12.07 (s, 1H); 13C
NMR (DMSO-d6) d: 23.6 (ACH3), 121.9, 125.6, 126.1, 128.0,
128.4, 128.8, 128.9, 129.2, 130.8, 130.9, 145.7, 147.5, 149.0
(C‚N), 158.1 (CAOH), 161.5 (AC‚O); elemental analysis
[C17H14N4O2] observed (calculated): C 66.57% (66.66%), H
4.50% (4.61%), N 18.22% (18.29%).
2.1.3. 2-[(2,3-dihydro-1H-inden-4-yl)oxy]-N0-[(E)-(2-
hydroxyquinolin-3-yl)methylidene]aceto hydrazide [3c]
M.P.: above 300 C; colour: faint yellow; MS [M+1]: 362.00;
FTIR (KBr cm1): 3210 (phenolicAOH), 3149 (NAH amide),
2952 (aromatic CAH), 2846 (aliphatic CAH), 1656 (C‚O
amide), 1614 (imine ACH‚NA), 1427 (phenolic CAO); 1H
NMR (DMSO-d6) d: 1.98–2.01 (m, 2H), 2.81–2.86 (m, 4H),
4.64 (s, 2H), 6.61–6.63 (m, 1H), 6.79–6.82 (m, 1H), 7.04–7.07
(m, 1H), 7.16–7.21 (m, 1H), 7.29–7.32 (m, 1H), 7.48–7.51 (m,
1H), 7.72–7.75 (m, 1H), 8.23 (s, 1H), 8.40–8.42 (m, 1H),
11.70 (s, 1H), 12.03 (s, 1H); 13C NMR (DMSO-d6) d: 25.5 (ali-
phatic CH2), 29.7 (aliphatic CH2), 32.5 (aliphatic CH2), 66.8
(aliphatic ACH2AOA), 113.7, 125.1, 126.4, 127.1, 128.0,
128.7, 128.8, 129.0, 130.3, 130.8, 135.1, 138.5, 146.1, 148.2
(C‚N), 155.8 (aromatic ACAOA), 160.5 (CAOH), 167.5
(AC‚O); elemental analysis [C21H19N3O3]: observed (calcu-
lated): C 69.87% (69.79%), H 5.34% (5.30%), N 11.56%
(11.63%).
2.1.4. N0-[(E)-(6-chloro-2-hydroxyquinolin-3-yl)methylidene]
pyridine-3-carbohydrazide [3d]
M.P.: 298 C; colour: yellow; MS [M+2]: 328.39; FTIR
(KBr cm1): 3214 (phenolicAOH), 3072 (NAH amide), 1656
(C‚O amide), 1617 (imine ACH‚NA), 1417 (phenolic
CAO); 1H NMR (DMSO-d6) d: 7.33–7.36 (m, 1H), 7.55–7.58
(m, 2H), 8.03 (s, 1H), 8.27–8.29 (m, 1H), 8.49 (s, 1H),
8.70–8.77 (m, 2H), 8.09 (s, 1H), 12.17 (s, 1H), 12.19 (s, 1H);
13C NMR (DMSO-d6) d: 123.5, 125.1, 126.6, 128.2, 130.2,
130.3, 130.5, 130.7, 132.3, 134.2, 146.1, 147.1, 148.2, 149.8
(C‚N), 160.5 (CAOH), 162.8 (AC‚O); elemental analysis
[C16H11ClN4O2]: observed (calculated): C 58.91% (58.82%),
H 3.44% (3.39%), N 17.23% (17.15%).
2.1.5. N0-[(E)-(6-chloro-2-hydroxyquinolin-3-yl)methylidene]-
6-methylpyridine-3-carbohydrazide [3e]
M.P.: 298 C; colour: yellow; MS [MAH]: 339.36; FTIR
(KBr cm1): 3237 (phenolicAOH), 3087 (NAH amide), 3006
(aromatic CAH), 2875 (aliphatic CAH), 1660 (C‚O amide),
1604 (imine ACH‚NA), 1415 (phenolic CAO); 1H NMR
(300 MHz, DMSO-d6) d: 2.55 (s, 3H), 7.32–7.42 (m, 2H),
7.55–7.57 (m, 1H), 8.01 (s, 1H), 8.16–8.19 (m, 1H), 8.47 (s,
1H), 8.69 (s, 1H), 8.97 (s, 1H), 12.09 (s, 1H), 12.14 (s, 1H);
13C NMR (DMSO-d6) d: 23.9 (ACH3), 122.0, 126.6, 127.1,
128.0, 128.6, 128.7, 128.8, 129.0, 130.5, 130.6, 146.1, 147.2,
147.9, 151.4 (C‚N), 161.5 (CAOH), 163.0 (AC‚O); elemen-
tal analysis [C17H13ClN4O2]: observed (calculated): C 59.99%
(59.92%), H 3.91% (3.85%), N 16.51% (16.44%).
2.1.6. N0-[(E)-(6-chloro-2-hydroxyquinolin-3-yl)methylidene]-
2-[(2,3-dihydro-1H-inden-4-yl)oxy]acetohydrazide [3f]
M.P.: >300 C; colour: yellow; MS [M+2]: 397.63; FTIR
(KBr cm1): 3185 (phenolicAOH), 3052 (NAH amide), 2921
(aromatic CAH), 2842 (aliphatic CAH), 1662 (AC‚O amide),Please cite this article in press as: M.C. Mandewale et al., Synthesis, structural studie
their Zn(II) complexes, Journal of Saudi Chemical Society (2016), http://dx.doi.org1616 (imine ACH‚NA), 1415 (CAO); 1H NMR (DMSO-d6)
d: 2.01 (m, 2H), 2.84–2.86 (m, 4H), 4.67 (s, 2H), 6.62–6.65
(m, 1H), 6.82–6.84 (m, 1H), 7.07 (m, 1H), 7.31–7.34 (m, 1H),
7.55–7.58 (m, 1H), 7.90 (m, 1H), 8.23 (s, 1H), 8.42–8.45 (m,
1H), 11.77 (m, 1H), 12.18 (s, 1H); 13C NMR (DMSO-d6) d:
25.1 (aliphatic CH2), 29.2 (aliphatic CH2), 31.6 (aliphatic
CH2), 65.8 (aliphatic ACH2AOA), 113.7, 124.7, 125.0, 125.6,
127.9, 130.3, 130.5, 130.7, 130.9, 133.5, 135.2, 137.6, 146.1,
148.4 (C‚N), 154.7 (aromatic ACAOA), 161.2 (CAOH),
167.3 (AC‚O); elemental analysis [C21H18ClN3O3]: observed
(calculated): C 63.79% (63.72%), H 4.50% (4.58%), N
10.57% (10.62%).2.1.7. N0-[(E)-(6-bromo-2-hydroxyquinolin-3-yl)methylidene]
pyridine-3-carbohydrazide [3g]
M.P.: 287 C; colour: dark yellow; MS [M+1]: 371.49; FTIR
(KBr cm1): 3241 (phenolicAOH), 3093 (NAH amide), 2902
(aromatic CAH), 1662 (C‚O amide), 1604 (imine
ACH‚NA1413 (phenolic CAO); 1H NMR (DMSO-d6) d:
7.25–7.28 (m, 1H), 7.56 (m, 1H), 7.66–7.68 (m, 1H), 8.15 (s,
1H), 8.25 (m, 1H), 8.46 (s, 1H), 8.68–8.76 (m, 2H), 9.07 (s,
1H), 12.15 (s, 2H); 13C NMR (DMSO-d6) d: 118.1, 124.9,
126.6, 128.1, 130.1, 130.4, 130.5, 130.7, 133.1, 133.8, 145.1,
146.2, 147.5, 149.7 (C‚N), 162.1 (CAOH), 163.2 (AC‚O);
elemental analysis [C16H11BrN4O2]: observed (calculated): C
51.82% (51.77%), H 3.06% (2.99%), N 15.01% (15.09%).2.1.8. N0-[(E)-(6-bromo-2-hydroxyquinolin-3-yl)methylidene]-
6-methylpyridine-3-carbohydrazide [3h]
M.P.: >300 C; colour: yellow; MS [M+]: 385.59; FTIR
(KBr cm1): 3214 (phenolicAOH), 3070 (NAH amide), 2838
(aliphatic CAH), 1656 (C‚O amide), 1612 (imine
ACH‚NA), 1473 (phenolic CAO); 1H NMR (DMSO-d6) d:
2.55 (s, 3H), 7.27–7.30 (m, 1H), 7.41–7.43 (m, 1H), 7.67–7.70
(m, 1H), 8.16 (m, 2H), 8.47 (s, 1H), 8.70 (s, 1H), 8.98 (s,
1H), 12.12 (s, 1H), 12.17 (s, 1H); 13C NMR (DMSO-d6) d:
22.8 (ACH3), 116.6, 121.9, 126.6, 127.9, 129.3, 130.1, 130.3,
130.5, 130.8, 133.4, 142.1, 144.2, 149.8, 152.1 (C‚N), 160.7
(CAOH), 163.1 (AC‚O); elemental analysis [C17H13BrN4O2]:
observed (calculated): C 52.91% (53.00%), H 3.42% (3.40%),
N 14.59% (14.54%).2.1.9. N0-[(E)-(6-bromo-2-hydroxyquinolin-3-yl)methylidene]-
2-[(2,3-dihydro-1H-inden-4-yl)oxy]acetohydrazide [3i]
M.P.: >300 C; colour: faint yellow; MS [M+2]: 441.56;
FTIR (KBr cm1): 3185 (phenolicAOH), 3045 (NAH amide),
2925 (aromatic CAH), 2840 (aliphatic CAH), 1662 (C‚O
amide), 1612 (imine ACH‚NA), 1567, 1479 (phenolic
CAO); 1H NMR (DMSO-d6) d: 1.99 (m, 2H), 2.81–2.84 (m,
4H), 4.65 (m, 2H), 6.61–6.63 (m, 1H), 6.80–6.82 (m, 1H),
7.05 (m, 1H), 7.23–7.26 (m, 1H), 7.63–7.66 (m, 1H), 8.00 (s,
1H), 8.20 (m, 1H), 8.50 (s, 1H), 11.75 (m, 1H), 12.15 (s, 1H);
13C NMR (DMSO-d6) d: 25.2 (aliphatic CH2), 29.6 (aliphatic
CH2), 32.6 (aliphatic CH2), 66.8 (aliphatic ACH2AOA),
113.7, 117.6, 125.0, 126.6, 127.9, 130.4, 130.6, 130.7, 130.8,
133.4, 135.1, 137.5, 146.1, 149.2 (C‚N), 155.8 (aromatic
ACAOA), 161.5 (CAOH), 168.5 (AC‚O); elemental analysis
[C21H18BrN3O3]: observed (calculated): C 48.52% (48.58%),
H 3.32% (3.30%), N 8.14% (8.09%).s and antituberculosis evaluation of new hydrazone derivatives of quinoline and
/10.1016/j.jscs.2016.04.003
6 M.C. Mandewale et al.3. Results and discussion
3.1. Chemistry
The target Zn(II) complexes 4a–4i were synthesized as depicted
in Fig. 2. The ﬁrst step involves the synthesis of derivatives of
2-hydroxy-3-carbaldehyde 1a–1c from corresponding acetani-
lide derivative via a Vilsmeier–Haack reaction as previously
reported [23–25]. Condensation of equimolar amounts of alde-
hyde 1a–1c with hydrazides 2a–2c in warming ethanol at 70 C
afforded hydrazones 3a–3i. Elemental analyses and spectral
data (FT-IR, 1H and 13C NMR, MS, UV–Visible and ﬂuores-
cence) conﬁrmed the structure of the products 3a–3i. The FT-
IR spectrum of hydrazone 3i, as a representative example,
showed strong absorption bands at 1662 and 1612 cm1 due
to a conjugated C‚N and C‚O functions, respectively. The
broad peak at 3185 cm1 is attributed to hydroxyl group,
which is present at the 2nd position of quinoline ring. The
important IR peaks and their assignments are listed in Table 3.
Its 1H NMR spectrum revealed, in addition to expected aro-
matic signals, three singlets at d 8.50, 11.75, 12.15 ppm are
assignable to the azomethine proton (ACH‚NA), hydroxyl
proton (AOH) and amide proton (ANHAC‚O), respectively.
In addition, the 13C NMR spectrum of 3i displayed three char-
acteristic peaks at d 149.2, 161.5, 168.5 ppm assignable to
imine carbon, carbon linked to the hydroxyl group of quino-
line and amide carbonyl carbon, respectively. Moreover the
mass spectrum of 3i revealed ion peak at m/z 441.56
(M+2) corresponding molecular formula [C21H18BrN3O3].
In a similar manner, compounds 3a–3h were prepared and
characterized.Table 3 1H NMR signals for hydrazones 3a–3i and their assignme
Schiﬀ base Amide ANH*A Phenolic
1H NMR d FTIR cm1 1H NMR
3a 12.13 3093 12.02
3b 12.07 3237 12.04
3c 12.03 3210 11.70
3d 12.19 3072 12.17
3e 12.14 3087 12.09
3f 12.18 3052 11.77
3g 12.15 3093 12.15
3h 12.17 3070 12.12
3i 12.15 3045 11.75
Table 4 FT-IR bands for metal complexes 4a–4i and their assignm
Complex Lattice water m(OH) cm
1 Imine m(C‚N) cm
1
4a 3446 1612
4b 3517 1612
4c 3370 1616
4d 3394 1614
4e 3330 1616
4f 3378 1616
4g 3394 1614
4h 3374 1616
4i 3300 1614
Please cite this article in press as: M.C. Mandewale et al., Synthesis, structural studie
their Zn(II) complexes, Journal of Saudi Chemical Society (2016), http://dx.doi.orgThe hydrazone ligand 3a–3i reﬂuxed with ZnCl2 in ethanol
with molar ratio 2:1 offer Zn(II) complexes 4a–4i. All metal
complexes show broad peaks in the region of 3330–
3517 cm1 due to coordinated water molecules. The coordina-
tion mode of hadrazone with central metal ion can be
explained on the basis of FTIR spectral study Table 4. The
phenolic AOH band appears at 3139–3488 cm1 which disap-
pears in IR spectra of the metal complexes, however new
broad peaks have been observed at 3330–3517 cm1 due to
coordinated water molecules which conﬁrms the complexation
of hydrazones with central metal atom through phenolic
AOH. The low frequency region of the spectra indicated the
presence of two new medium intensity bands at about 443–
485 cm1 due to mMAO vibrations. The IR spectra of all the
metal complexes show prominent band at about 501–
620 cm1 due to mMAN stretching.
The magnetic study shows all Zinc(II) complexes were dia-
magnetic in nature. The DSC–TGA analysis was carried out to
explain the thermal stability of the complexes. The thermal
behaviour of the metal complex 4e Fig. 3 was studied in the
temperature range of 25–1000 C. The TG–DTA studies of
complex 4e show that the decomposition proceeds in three
steps. In the ﬁrst stage, weight loss below 100 C corresponds
to the presence of the lattice cell water in the complexes. Sec-
ond step involves weight loss in the temperature range 110–
200 C which is due to elimination of coordinated water. A
plateau observed above 600 C corresponds to the formation
of stable Zinc oxide. Observed Zn content of the metal com-
plexes is in good agreement with the theoretical values as
shown in Table 5.
The X-ray powder diffraction data provide vital structural
information of materials which do not yield single crystals ofnts.
AOH Imine ACH‚NA
d FTIR cm1 1H NMR d FTIR cm1
3237 9.02 1625
3453 8.97 1600
3149 8.23 1614
3214 8.09 1617
3237 8.69 1604
3185 8.45 1616
3241 9.07 1604
3214 8.98 1612
3185 8.50 1612
ents.
Phenolic m(C–O) cm
1 m(M–N) cm
1 m(M–O) cm
1
1423 576 472
1430 572 468
1446 611 474
1411 555 476
1415 570 465
1415 570 466
1411 532 474
1411 535 443
1413 540 468
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Figure 3 The DSC-TGA analysis of Zn(II) complex 4e.
Table 5 Molar conductance (Km) and% content of Zn in
metal complexes 4a–4i.
Complex Molar conductance Km
(X1 mol1 cm2)
% Zn observed
(calculated)
4a 8.9 10.03 (9.56)
4b 4.1 9.06 (9.18)
4c 7.9 8.01 (7.95)
4d 6.4 8.73 (8.69)
4e 6.4 8.27 (8.37)
4f 8.8 7.39 (7.34)
4g 6.0 8.00 (7.77)
4h 8.7 7.61 (7.52)
4i 6.2 6.72 (6.67)
Hydrazone derivatives of quinoline and their Zn(II) complexes 7good quality. Single crystals of the complexes under study
could not be prepared thus the powder diffraction data were
acquired for structural description [26]. The X-ray diffrac-
togram of the complex was measured in the range of 5–80
2h values. The XRD pattern indicates that complex 4e has well
deﬁned crystalline patterns, with various degrees of crys-
tallinity Fig. 4. The average crystallite size of the complex
was calculated using Scherer’s formula [27,28]. The Zn(II)
complex 4e has an average crystallite size of 59 nm.
From the mathematical relation Km= K/C the molar con-
ductance of the metal complexes (Km) can be calculated by dis-
solving in a proper solvent where C is the molar concentration
of the metal complex solutions [29]. The metal complexes 4a–4i
were dissolved in DMF to prepare 103 M of their solutions.
The molar conductivities were measured at 25 ± 2 C. The
study shows negligible molar conductance values for metal
complexes 4a–4i (4.1–8.9 X1 mol1 cm2), indicating that thePlease cite this article in press as: M.C. Mandewale et al., Synthesis, structural studie
their Zn(II) complexes, Journal of Saudi Chemical Society (2016), http://dx.doi.orgcomplexes are non-electrolytes. The results are represented in
Table 5. From the experimental study, it is clear that practical
observations are in good agreement with the theoretical values
calculated for 1:2 ratio of metal:ligand stoichiometry. From
the above explanation of the results of various spectroscopic
details it may be concluded that the proposed geometry
for the transition metal complexes with general formula
ML22H2O is octahedral for Zn(II) complexes. The proposed
structures are shown in Table 2.
3.2. Anti-tuberculosis evaluation
The anti-microbial effects of the new hydrazones and their
Zinc complexes against M. tuberculosis (H37 RV strain)
ATCC No-27294, were evaluated at the Department of Micro-
biology, Maratha Mandal’s NGH Institute of Dental Sciences
and Research Centre, Belgaum-590010, India. The method
applied is similar to that reported by Maria and Lourenco
[30]. Ciproﬂoxacin (MIC 9.41 lM), Pyrazinamide (MIC
25.34 lM) and Streptomycin (MIC 10.74 lM) were used as
references to evaluate the potency of the synthesized com-
pounds. As shown in Table 6 and Fig. 5, complexes 4e and
4g have unpredictable high anti-tuberculosis activity against
M. tuberculosis as their MIC value is 8.00 lM and 7.42 lM
respectively. All the studied samples are showing different
potencies due to the effective barrier of an outer cell wall mem-
brane of M. tuberculosis for entry of external substances like
test compounds under this study. However, hydrazone ligands
3a–3i showed less activity than their Zn(II) complexes 4a–4i.
This could be as a result of the metal chelates, which bear polar
and nonpolar properties together; this makes them suitable for
permeation to the bacterial cell. This ﬁnding indicates thats and antituberculosis evaluation of new hydrazone derivatives of quinoline and
/10.1016/j.jscs.2016.04.003
Figure 4 XRD spectra of Zn(II) complex 4e.
Table 6 Showing comparative anti-tuberculosis screening
results by MIC method.
Test sample Sample
concentration
in lM (MIC)
Test sample Sample
concentration
in lM (MIC)
3a 171.17 4a 36.55
3b 163.22 4b 17.60
3c 69.17 4c 30.40
3d 76.51 4d 16.60
3e 73.36 4e 8.00
3f 126.31 4f 14.02
3g 67.35 4g 7.42
3h 32.55 4h 14.37
3i 56.78 4i 25.51
Ciproﬂoxacin* 9.41 Pyrazinamide* 25.34
Streptomycin* 10.74
* Standard.
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Figure 5 MIC in lM of tested compounds against Mycobacterium tuberculosis.
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Figure 6 Electronic spectra of hydrazones (3a–3i).
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Hydrazone derivatives of quinoline and their Zn(II) complexes 9complex formation enhanced the amphiphilic properties and
solubility and hence, the penetration of complex 4e and 4g into
the cell wall of theM. tuberculosis, which translated into better
activity. According to the Molecular Theory of Coordination
metal orbital overlap with ligand orbitals this decreases the
positive charge on the metal ion by accepting the electrons
from donor groups of the hydrazone ligand [31,32]. Thus,
the donation of the electrons from ligand to metal also favours
the increased delocalization of the p-electrons through entire
coordinating rings. This results in increased lipophilicity of
the metal complexes. Hence, the improved lipophilicity facili-0 
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Figure 7 Electronic spectra of complexes (4a–4i).
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Figure 8 Fluorescence spectra of hydrazones (3a–3i).
Table 7 The absorption and emission wavelength with intensity.
Hydrazone Absorption kmax (intensity) Emission kmax (intensity)
3a 381 (3.01) 445 (45.95)
3b 382 (3.34) 454 (14.06)
3c 364 (4.00) 440 (76.41)
3d 386 (2.33) 454 (96.27)
3e 386 (3.12) 465 (26.94)
3f 382 (1.69) 449 (403.35)
3g 387 (0.61) 459 (49.72)
3h 386 (0.42) 458 (139.82)
3i 381 (0.41) 450 (246.28)
Please cite this article in press as: M.C. Mandewale et al., Synthesis, structural studie
their Zn(II) complexes, Journal of Saudi Chemical Society (2016), http://dx.doi.orgtates the transport of the complexes across the lipid cell mem-
brane of the bacteria thus, it can block the metal binding sites
on different enzymes of bacteria [33,34]. These metal com-
plexes interact with the DNA gyrase enzyme, which is neces-
sary for DNA multiplication step. The DNA gyrase is
inhibited by metal complexes, which alter the multiplication
of bacterial cells, eventually resulting in the death of the bacte-
ria [35,36].
The observed results of the test compounds indicate the
future potential for the development of metal coordination
complexes to solve the limitations due to currently existing
anti-tuberculosis agents to treat tuberculosis.
3.3. Fluorescence study
The UV–Visible spectra of the ligands 3a–3i in exhibit bands
around 364–387 nm as represented in Fig. 6. The broad,
intense band around 310 nm in the ligands can be assigned
to intra ligand n–p* transition associated with the azomethine
linkage. Fig. 7 shows this band experiences red shift in all the
complexes 4a–4i. The bands at around 386–408 nm are attrib-
uted to the ligand to metal charge transfer transitions.
The emission spectra of compounds 3a–3i (Fig. 8) showed
the emission band in the range of 440–459 nm and complexes
4a–4i (Fig. 8) Table 7 showed emission band in the range of
456–485 nm. Complex formation of hydrazones induces a
marked hyperchromic and bathochromic shifts. The Zn(II)
complexes demonstrated intense ﬂuorescent properties as com-
pared to their parent ligands. The incorporation of Zn(II)Complex Absorption kmax (intensity) Emission kmax (intensity)
4a 399 (0.64) 473 (703.56)
4b 402 (3.27) 475 (226.04)
4c 386 (1.89) 460 (544.80)
4d 408 (1.49) 481 (546.76)
4e 407 (2.53) 482 (449.49)
4f 395 (1.27) 467 (785.49)
4g 408 (0.221) 482 (851.90)
4h 408 (0.405) 481 (555.31)
4i 394 (0.579) 467 (518.87)
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Figure 9 Fluorescence spectra of complexes (4a–4i).
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10 M.C. Mandewale et al.effectively increases the conformational rigidity of the hydra-
zones and increases the ﬂuorescence intensities of complexes
4a–4i, which shows that it is good material in photochemical
applications of these complexes (Fig. 9).4. Conclusions
In conclusions, the objectives of the present study were to syn-
thesize some new hydrazone derivatives with quinoline core
and to perform antituberculosis analysis by blue almar method
to identify the more effective compound and subsequently per-
form UV and ﬂuorescence study. Most of the synthesized com-
pounds show moderate to good antituberculosis properties.
This study would pave the way for future development of more
effective quinoline hydrazone analogues for biological and
material applications.Acknowledgments
The authors thank Principal and Head Department of
Chemistry, Government of Maharashtra, Ismail Yusuf Arts,
Science and Commerce College for providing research and
library facilities. The authors also thank Dr. Kishore Bhat of
Governmental Dental College, Belgaum, for facilitating
anti-TB assays and providing the procedure for the same.References
[1] A. Koul, E. Arnoult, N. Lounis, J. Guillemont, K. Andries, The
challenge of new drug discovery for tuberculosis, Nature 469
(2011) 483–490.
[2] R.C. Goldman, B.E. Laughon, Discovery and validation of new
antitubercular compounds as potential drug leads and probes,
Tuberculosis (Edinb) 89 (2009) 331–333.
[3] D. Murugesan, S. Palaniappan, Y. Perumal, C. Arnab, N.
Valakunja, S. Dharmarajan, Bioorg. Med. Chem. 16 (2008)
3408–3418.
[4] L. Annamaria, M. Jialin, W. Baojie, W. Yuehong, G.F. Scott, P.
K. Alan, J. Med. Chem. 52 (2009) 2109–2118.
[5] J. Sarva, I. Yasuyoshi, W. Baojie, G.F. Scott, P.K. Alan, Chem.
Med. Chem. 1 (2006) 593–597.
[6] N. Amit, M. Vikramdeep, M. Alpeshkumar, C. Evans, J. Rahul,
Bioorg. Med. Chem. 15 (2007) 626–640.
[7] M. Dinakaran, P. Senthilkumar, P. Yogeeswari, A. China, V.
Nagaraja, S. Dharmarajan, Int. J. Antimicrob. Agents 31 (2008)
337–344.
[8] L. Savini, L. Chiasserini, A. Gaeta, C. Pellerano, Bioorg. Med.
Chem. 10 (2002) 2193–2198.
[9] S. Eswaran, A.V. Adhikari, I.H. Chowdhury, N.K. Pal, K.D.
Thomas, New quinoline derivatives: synthesis and investigation
of antibacterial and antituberculosis properties, Eur. J. Med.
Chem. 45 (2010) 3374–3383.
[10] E. Vavrı´kova, S. Polanc, M. Kocevar, K. Horvati, S. Bosze, J.
Stoları´kova, et al, New ﬂuorine-containing hydrazones active
against MDR-tuberculosis, Eur. J. Med. Chem. 46 (2011) 4937–
4945.
[11] S. Rollas, S.G. Ku¨c¸u¨kgu¨zel, Molecules 12 (2007) 1910–1939.
[12] S. Rao, D.D. Mishra, R.V. Mourya, N. Nageswara,
Oxovanadium binuclear (IV) Schiff base complexes derived
from aroyl hydrazones having subnormal magnetic moment,
Polyhedron 16 (1997) 1825–1829.
[13] D.X. West, A.E. Liberta, S.B. Padhye, R.C. Chikate, P.B.
Sonawane, A.S. Kumbhar, R.G. Yerande, ThiosemicarbazonePlease cite this article in press as: M.C. Mandewale et al., Synthesis, structural studie
their Zn(II) complexes, Journal of Saudi Chemical Society (2016), http://dx.doi.orgcomplexes of copper(II): structural and biological studies,
Coord. Chem. Rev. 123 (1993) 49–71.
[14] B.L. Vallee, D.S. Auld, Biochemistry 29 (1990) 5647.
[15] A.I. Bush, Curr. Opin. Chem. Biol. 4 (2000) 184.
[16] T.B. Cole, A. Martyanova, R.D. Palmiter, Brain Res. 891 (2001)
253.
[17] H. Tapiero, K.D. Tew, Biomed. Pharmacother. 57 (2003) 399.
[18] Z.H. Chohan, M.A. Farooq, Pak. J. Pharm. Sci. 7 (1994) 45.
[19] S. Eswaran, A.V. Adhikari, N.K. Pal, I.H. Chowdhury, Design
and synthesis of some new quinoline-3-carbohydrazone
derivatives as potential antimycobacterial agents, Bioorg. Med.
Chem. Lett. 20 (2010) 1040–1044.
[20] K.D. Thomas, A.V. Adhikari, S. Telkar, I.H. Chowdhury, R.
Mahmood, N.K. Pal, et al, Design, synthesis and docking
studies of new quinoline-3-carbohydrazide derivatives as
antitubercular agents, Eur. J. Med. Chem. 46 (2011) 5283–5292.
[21] M.C. Mandewale, B.R. Thorat, D. Shelke, R.S. Yamgar,
Synthesis and biological evaluation of new hydrazone
derivatives of quinoline and their Cu(II) and Zn(II) complexes
against Mycobacterium tuberculosis, Bioinorg. Chem. Appl.
2015 (2015) 14, http://dx.doi.org/10.1155/2015/153015.
[22] M.C. Mandewale, B.R. Thorat, R.S. Yamgar, Synthesis and
anti-mycobacterium study of some ﬂuorine containing Schiff
bases of quinoline and their metal complexes, Der Pharma
Chem. 7 (2015) 207–215.
[23] O. Meth-Cohn, B. Narine, B. Tarnowski, A versatile new
synthesis of quinolines and related fused pyridines. Part 5. The
synthesis of 2-chloroquinoline-3-carbaldehydes, J. Chem. Soc.
Perkin Trans. 1 (1981) 1520–1530.
[24] M. Mustapha, B.R. Thorat, S.S. Sawant, R.G. Atram, R.S.
Yamgar, Synthesis of novel Schiff bases and its transition metal
complexes, J. Chem. Pharm. Res. 3 (2011) 5–9.
[25] Ambika Shrivastav, R.M. Singh, Vilsmeier–Haack reagent: a
facile synthesis of 2-chloro-3-formylquinoline from n-
arylacetamides and transformation into different
functionalities, Indian J. Chem. 44B (2005) 1868–1875.
[26] H.A. Bayoumi, M.A. Abdel-Nasser, Mutlak S.H. Aljahdali, Cu
(II), Ni(II), Co(II) and Cr(III) complexes with N2O2-chelating
Schiff’s base ligand incorporating azo and sulfonamide moieties:
spectroscopic, electrochemical behavior and thermal
decomposition studies, Int. J. Electrochem. Sci. 8 (2013) 9399–
9413.
[27] C.J. Dhanaraj, M.S. Nair, Synthesis, characterization, and
antimicrobial studies of some Schiff-base metal(II) complexes,
J. Coord. Chem. 62 (2009) 4018–4028.
[28] C.J. Dhanaraj, M.S. Nair, Synthesis and characterization of
metal(II) complexes of poly(3-nitrobenzylidene-1-
naphthylamineco-succinicanhydride), Eur. Polym. J. 45 (2009)
565–572.
[29] G.G. Mohamed, M.M. Omar, A.M. Hindy, Metal complexes of
schiff bases: preparation characterization and biological activity,
Turk. J. Chem. 30 (2006) 361–382.
[30] M.S. Lourenco, M.N. DeSouza, A.C. Pinheiro, M.L. Ferreira,
R.B. Goncalves, T.M. Nogneira, M.A. Peralta, Evaluation of
anti-tubercular activity of nicotinic and isoniazid analogues,
ARKIVOC 15 (2007) 181–191.
[31] A.K. Kralova, K. Kissova, O. Svajlenova, J. Vanco, Biological
activity of copper(II) N-salicylideneaminoacidato complexes.
Reduction of chlorophyll content in freshwater alga Chlorella
vulgaris and inhibition of photosynthetic electron transport in
spinach chloroplasts, Chem. Pap. 58 (2004) 357–361.
[32] J. Parekh, P. Inamdhar, R. Nair, S. Baluja, S. Chanda, Synthesis
and antibacterial activity of some Schiff bases derived from 4-
aminobenzoic acid, J. Serb. Chem. Soc. 70 (2005) 1155–1161.
[33] Y. Vaghasia, R. Nair, M. Soni, S. Baluja, S. Chanda, Synthesis,
structural determination and antibacterial activity of
compounds derived from vanillin and 4-aminoantipyrine, J.
Serb. Chem. Soc. 69 (2004) 991–998.s and antituberculosis evaluation of new hydrazone derivatives of quinoline and
/10.1016/j.jscs.2016.04.003
Hydrazone derivatives of quinoline and their Zn(II) complexes 11[34] N. Raman, Antibacterial study of the mannich base, N-(1-
morpholino-benzyl) semicarbazide and its transition metal(II)
complexes, Res. J. Chem. Environ. 4 (2005) 9.
[35] U. Galm, S. Heller, S. Shapiro, M. Page, S.M. Li, L. Heide,
Antimicrobial and DNA gyrase-inhibitory activities of novelPlease cite this article in press as: M.C. Mandewale et al., Synthesis, structural studie
their Zn(II) complexes, Journal of Saudi Chemical Society (2016), http://dx.doi.orgclorobiocin derivatives produced by mutasynthesis, Antimicrob.
Agents Chemother. 48 (2004) 1307–1312.
[36] E.J. Alvarez, V.H. Vartanian, J.S. Brodbelt, Metal
complexation reactions of quinolone antibiotics in a
quadrupole ion trap, Anal. Chem. 69 (1997) 1147–1155.s and antituberculosis evaluation of new hydrazone derivatives of quinoline and
/10.1016/j.jscs.2016.04.003
